Riddhi Siddhi Gluco Biols accepts director resignation

1 min read     Updated on 22 Jun 2026, 09:57 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Riddhi Siddhi Gluco Biols Ltd accepted the resignation of Independent Director Pratik Mahendra Shah effective June 22, 2026, due to increased business commitments. The company confirmed compliance with SEBI regulations regarding the disclosure of this cessation.

powered bylight_fuzz_icon
43691226

*this image is generated using AI for illustrative purposes only.

Riddhi Siddhi Gluco Biols Ltd has accepted the resignation of Pratik Mahendra Shah as Independent Director, effective June 22, 2026. The resignation was submitted due to increased commitments arising from the growth of his own business, which requires greater time, attention, and focus. This change impacts the company's board composition as it continues its operations.

The company disclosed the information in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was also made in accordance with Para 7 and 7B of Schedule III Part A of the regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026.

Resignation Details

Pratik Mahendra Shah confirmed that there are no other material reasons for his resignation beyond the stated business commitments. He expressed gratitude to the Board of Directors for the support and cooperation during his tenure. The resignation was formally accepted by the company on June 22, 2026.

The following table summarizes the key details of the cessation:

Sr. No. Particulars Information
1 Reason for change Resignation of Mr. Pratik Mahendra Shah (DIN: 01738382) Independent Director of the Company w.e.f., 22 June, 2026.
2 Date of cessation Cessation w.e.f., 22 June, 2026.
6 Directorships in listed entities NIL
7 Confirmation on material reasons Mr. Pratik Mahendra Shah has confirmed that there are no material reasons for his resignation other than those mentioned in his resignation letter.

Regulatory Compliance

The filing included the letter of resignation and the necessary disclosures as required by the Listing Regulations. The company confirmed that all procedural requirements have been met regarding the intimation to the stock exchanges. The resignation has been recorded in the company's official registers.

Historical Stock Returns for Riddhi Siddhi Gluco Biols

1 Day5 Days1 Month6 Months1 Year5 Years
-0.33%+5.91%+22.90%+76.54%+44.24%+156.28%

Who will Riddhi Siddhi Gluco Biols appoint to fill the vacancy of the Independent Director?

How will the reduction in board size impact the company's corporate governance oversight?

Is the company planning to reconstitute any board committees following this resignation?

Riddhi Siddhi Gluco Biols
View Company Insights
View All News
like18
dislike

Riddhi Siddhi Gluco Biols promoter to sell 8.23 lakh shares at ₹730 floor price

1 min read     Updated on 19 Jun 2026, 05:30 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Vital Connections LLP, a promoter of Riddhi Siddhi Gluco Biols Ltd, announced an Offer for Sale of 8,23,422 equity shares (11.55%) on June 22, 2026, at a floor price of ₹730 to comply with SEBI's Minimum Public Shareholding norms. The offer will be conducted on BSE, with non-retail bidding on June 22 and retail bidding on June 23, managed by Kotak Securities Limited.

powered bylight_fuzz_icon
43084364

*this image is generated using AI for illustrative purposes only.

Vital Connections LLP, a promoter group shareholder of Riddhi Siddhi Gluco Biols Ltd, will offer 8,23,422 equity shares representing 11.55% of the total paid-up equity share capital on June 22, 2026. The Offer for Sale (OFS) aims to achieve Minimum Public Shareholding (MPS) compliance of 25% as directed by the Securities and Exchange Board of India (SEBI) and the Securities Appellate Tribunal (SAT). The floor price for the offer has been set at ₹730 per equity share.

The OFS will be conducted through a separate window on BSE Limited. Non-retail investors can bid on June 22, 2026 (T Day), while retail investors and non-retail investors carrying forward unallotted bids can participate on June 23, 2026 (T+1 Day). Kotak Securities Limited has been appointed as the seller's broker for the transaction. The offer follows a SAT order dated March 9, 2026, which modified the restraint period on the promoter to six months post-compliance.

The allocation methodology reserves a minimum of 10% of the offer shares for retail investors and 25% for mutual funds and insurance companies. Bidders must deposit 100% of the bid value upfront for non-institutional investors in the non-retail category, while institutional investors have the option to bid without upfront payment. The seller reserves the right to withdraw or cancel the offer if sufficient demand is not received at or above the floor price.

The offer details are summarized below:

Particulars Details
Seller Vital Connections LLP
Shares Offered 8,23,422 Equity Shares (11.55%)
Floor Price ₹730 per share
T Day (Non-Retail) June 22, 2026
T+1 Day (Retail) June 23, 2026
Broker Kotak Securities Limited

The offer is subject to the SEBI OFS Circular and the operational guidelines issued by BSE. Upon completion, the public shareholding is projected to increase to the mandated 25% threshold, with promoters holding the remaining 75%. The company will disclose the outcome to the stock exchanges following the offer.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE249D01019/d28d4d25-af76-4b6b-b66d-8d91b6a22c8f.pdf

Historical Stock Returns for Riddhi Siddhi Gluco Biols

1 Day5 Days1 Month6 Months1 Year5 Years
-0.33%+5.91%+22.90%+76.54%+44.24%+156.28%

How will the completion of this OFS and the subsequent increase in public float impact Riddhi Siddhi Gluco Biols' liquidity and stock volatility?

What is the market sentiment regarding the floor price of ₹730, and is there potential for a significant discount or premium during the bidding process?

How will the company's strategy evolve post-compliance to maintain the 25% public shareholding threshold without further promoter dilution?

Riddhi Siddhi Gluco Biols
View Company Insights
View All News
like18
dislike

More News on Riddhi Siddhi Gluco Biols

1 Year Returns:+44.24%